17-34256892-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002982.4(CCL2):c.*65C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 923,064 control chromosomes in the GnomAD database, including 45,576 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.29   (  6917   hom.,  cov: 32) 
 Exomes 𝑓:  0.30   (  38659   hom.  ) 
Consequence
 CCL2
NM_002982.4 3_prime_UTR
NM_002982.4 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.224  
Publications
57 publications found 
Genes affected
 CCL2  (HGNC:10618):  (C-C motif chemokine ligand 2) This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020] 
CCL2 Gene-Disease associations (from GenCC):
- neural tube defects, susceptibility toInheritance: AD Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CCL2 | ENST00000225831.4  | c.*65C>T | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_002982.4 | ENSP00000225831.4 | |||
| CCL2 | ENST00000624362.2  | n.1608C>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| CCL2 | ENST00000580907.6  | c.*549C>T | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000462156.1 | 
Frequencies
GnomAD3 genomes   AF:  0.287  AC: 43568AN: 151918Hom.:  6905  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
43568
AN: 
151918
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.298  AC: 229448AN: 771026Hom.:  38659  Cov.: 10 AF XY:  0.298  AC XY: 119827AN XY: 402548 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
229448
AN: 
771026
Hom.: 
Cov.: 
10
 AF XY: 
AC XY: 
119827
AN XY: 
402548
show subpopulations 
African (AFR) 
 AF: 
AC: 
3682
AN: 
19294
American (AMR) 
 AF: 
AC: 
16349
AN: 
31906
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
5496
AN: 
19542
East Asian (EAS) 
 AF: 
AC: 
21702
AN: 
35060
South Asian (SAS) 
 AF: 
AC: 
21294
AN: 
63754
European-Finnish (FIN) 
 AF: 
AC: 
17258
AN: 
50330
Middle Eastern (MID) 
 AF: 
AC: 
1207
AN: 
4292
European-Non Finnish (NFE) 
 AF: 
AC: 
131757
AN: 
509932
Other (OTH) 
 AF: 
AC: 
10703
AN: 
36916
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 7261 
 14521 
 21782 
 29042 
 36303 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 2914 
 5828 
 8742 
 11656 
 14570 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.287  AC: 43608AN: 152038Hom.:  6917  Cov.: 32 AF XY:  0.296  AC XY: 21971AN XY: 74310 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
43608
AN: 
152038
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
21971
AN XY: 
74310
show subpopulations 
African (AFR) 
 AF: 
AC: 
8389
AN: 
41448
American (AMR) 
 AF: 
AC: 
6582
AN: 
15272
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
979
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2870
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
1652
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
3635
AN: 
10566
Middle Eastern (MID) 
 AF: 
AC: 
88
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
18685
AN: 
67982
Other (OTH) 
 AF: 
AC: 
600
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1561 
 3122 
 4684 
 6245 
 7806 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 454 
 908 
 1362 
 1816 
 2270 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1529
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.